McFarlane Neil F.
SEC CIK 1681098 · EDGAR
BoughtSold
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-09 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $8.56 | -14.6K | 387.2K | -4% | -$125.2K |
| D | 2026-02-10 | 2026-02-07 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +37.5K | 401.9K | +10% | — |
| D | 2026-02-02 | 2026-02-02 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $9.38 | -91.0K | 364.4K | -20% | -$853.6K |
| D | 2026-02-02 | 2026-01-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +233.3K | 455.4K | +105% | — |
| D | 2025-10-10 | 2025-10-10 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +50.0K | 241.5K | +26% | — |
| D | 2025-10-10 | 2025-10-10 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $10.82 | -19.5K | 222.0K | -8% | -$211.0K |
| M | 2025-02-14 | 2025-02-13+ | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | S - Sale | $7.92 | -91.8K | 222.1K | -29% | -$727.5K |
| D | 2025-02-03 | 2025-01-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +233.3K | 283.3K | +467% | — |
| 2024-05-16 | 2024-05-16 | COLL | COLLEGIUM PHARMACEUTICAL, INC | McFarlane Neil F. | Dir | A - Grant | $0.00 | +7,693 | 49.4K | +18% | $0 | |
| 2023-05-19 | 2023-05-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | McFarlane Neil F. | Dir | A - Grant | $0.00 | +9,792 | 41.7K | +31% | $0 | |
| 2022-05-23 | 2022-05-19 | COLL | COLLEGIUM PHARMACEUTICAL, INC | McFarlane Neil F. | Dir | A - Grant | $0.00 | +14.0K | 31.9K | +79% | $0 | |
| 2022-04-08 | 2022-04-06 | COLL | COLLEGIUM PHARMACEUTICAL, INC | McFarlane Neil F. | Dir | A - Grant | $0.00 | +17.8K | 17.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations